Updated Oct 9, 2026 · 04:30 UTC
EWEdwards Lifesciences Corp
Health Care · United States · XNYS · orthopedic, prosthetic & surgical appliances & supplies
$84.28−1.80%last session · market closed
Market cap
$48.58b
real-world
Tokenized
$58
<0.001% of the asset
Avg token price
$86.19
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
EW · Price
Apr 28, 2025low $72.75 · high $96.10 · now $85.65Oct 8, 2026
Earnings
Nasdaq’s earnings calendar
Next earnings
Nov 4
after the close · Sep 2026 quarter · EPS forecast $0.73 (9 analysts)
Last earnings, Jul 23
$0.78 EPS
+6.8% vs $0.73 forecast · Jun 2026 quarter
Real market
Edwards Lifesciences Corp
Last close
$85.78
Oct 7
Traded on Oct 7
$302.0m
Price now
$84.28
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
Onchain versions
1 token from 1 issuer
wEWxBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
In DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$6.51b
+15% YoY
Operating income
$1.45b
22% margin · −1% YoY
Net income
$1.00b
15% margin · −76% YoY
EPS, diluted
$1.74
−75% YoY
Gross margin
78%
Cash and balance sheet
Free cash flow
$1.43b
22% of revenue
Net cash
$3.65b
$4.25b cash and securities, $598.7m debt
Diluted shares
578m
−2% YoY
Valuation at today’s market cap
P/E
48×
EV / sales
6.9×
enterprise value $44.92b
EV / operating income
31.0×
Free cash flow yield
3.0%
Quarterly
RevenueNet income